Powell Andrew Kenneth William

CIK 00013041138 companiesCARY, NC

SEC Profile

Transactions

Companies

Filings

CIK

0001304113

Recent Transactions

50 trades

Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-06-01+4,660→ 33,523 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2024-06-01−4,660→ 0 total
Purchase
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-03-04$1.25/sh+6,000→ 28,863 total
Purchase
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2024-03-01$1.23/sh+8,500→ 22,863 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2023-06-02+4,507→ 14,363 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2023-06-02−4,507→ 0 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2023-06-01+4,660→ 4,660 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock Option (Right to Buy)
2023-06-01+15,750→ 15,750 total
Gift
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2022-11-08−4,000→ 9,856 total
Award
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (right to buy)
2022-06-10+18,000→ 18,000 total
Award
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Common Stock
2022-06-04$9.50/sh+7,059→ 27,477 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Restricted Stock Unit
2022-06-04$9.50/sh−7,059→ 0 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2022-06-03+3,356→ 13,856 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2022-06-03−3,356→ 0 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock Option (Right to Buy)
2022-06-02+15,750→ 15,750 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2022-06-02+4,507→ 4,507 total
Award
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Restricted Stock Unit
2022-05-31+9,474→ 9,474 total
Gift
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2022-05-16−709→ 10,500 total
Gift
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2021-11-23−5,500→ 11,209 total
Award
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Restricted Stock Unit
2021-06-04+7,059→ 7,059 total
Award
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (right to buy)
2021-06-04+15,000→ 15,000 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2021-06-03+3,356→ 3,356 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock Option (Right to Buy)
2021-06-03+12,250→ 12,250 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Restricted Stock Unit
2021-06-01$11.64/sh−8,303→ 0 total
Award
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Common Stock
2021-06-01$11.64/sh+8,303→ 20,418 total
Award
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (right to buy)
2020-12-03+21,009→ 21,009 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Restricted Stock Unit
2020-10-15−2,200→ 0 total
Award
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Common Stock
2020-10-15$10.36/sh+2,200→ 12,115 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2020-06-06+7,333→ 16,709 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2020-06-06−7,333→ 0 total
Award
Aclaris Therapeutics, Inc.$ACRS
Option Grant (right to buy)
2020-06-04+16,500→ 16,500 total
Award
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Right to Buy Restricted Stock Unit (RSU)
2020-06-01+8,303→ 8,303 total
Award
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Common Stock
2020-05-28$10.99/sh+6,000→ 9,915 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Restricted Stock Unit
2020-05-28−6,000→ 0 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2020-03-02+8,876→ 9,376 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted stock units
2020-03-02+8,876→ 8,876 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted stock units
2020-03-02−8,876→ 0 total
Disposition to Issuer
Synthorx, Inc.
Stock Option (right to buy)
2020-01-23$54.00/sh−27,015→ 0 total
Disposition to Issuer
Synthorx, Inc.
Stock Option (right to buy)
2020-01-23$55.60/sh−6,389→ 0 total
Award
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Right to Buy Restricted Stock Unit (RSU)
2019-10-15+2,200→ 2,200 total
Award
Synthorx, Inc.
Stock Option (right to buy)
2019-06-07+6,389→ 6,389 total
Award
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2019-06-06+7,333→ 7,333 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Common Stock
2019-05-30$9.91/sh+2,915→ 3,915 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Restricted Stock Unit
2019-05-30−2,915→ 0 total
Award
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Right to Buy Restricted Stock Unit (RSU)
2019-05-28+6,000→ 6,000 total
Exercise/Conversion
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Right to Buy Restricted Stock Unit (RSU)
2019-01-30+2,915→ 2,915 total
Purchase
LIFECORE BIOMEDICAL, INC. \DE\$LFCR
Common Stock
2019-01-11$11.62/sh+525→ 1,000 total
Award
Synthorx, Inc.
Stock Option (right to buy)
2018-12-19+27,015→ 27,015 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock Option (right to buy)
2018-06-07+8,000→ 8,000 total
Purchase
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2018-05-16$19.12/sh+500→ 500 total

Companies

Recent Filings

Address

C/O CORNERSTONE THERAPEUTICS 1255 CRESCENT GREEN DRIVE, SUITE 250

CARY, NC, 27518

View on SEC.gov